Pharma Firms' "Soft Money" Donations To GOP

7 September 1997

The US nonprofit group Common Cause has reported that in the first sixmonths after the Presidential election in November 1996, pharmaceutical and medical supplies manufacturers donated $779,500 to the Republican Party in "soft money;" ie money given to a national political party which the party can then spend any way it wants. Corporations and unions can only give a set amount to individual candiates, but by giving to the party, election limits can essentially be circumvented.

This figure compares to only $133,735 donated in this manner in the same period after the 1992 election, according to the CC report.

The general health industry donated $522,000 in soft money to the Republicans during January-June 1996, compared with only $46,900 in the same 1993 period. Soft-money donations from pharmaceutical and medical suppliers to the Democrats hit $404,800 in the first six months of 1997, compared with $225,500 in the same 1993 period, while general health industry soft money to Democrats fell to $137,000 from $173,000 in the comparable 1993 period.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight